ProShare Advisors LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 92 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$224,000
-5.5%
131,537
-3.6%
0.00%0.0%
Q2 2018$237,000
-11.2%
136,433
-6.4%
0.00%0.0%
Q1 2018$267,000
-29.6%
145,831
-14.1%
0.00%
-33.3%
Q4 2017$379,000
-8.2%
169,802
+19.3%
0.00%
-25.0%
Q3 2017$413,000
-31.5%
142,291
+5.0%
0.00%
-33.3%
Q2 2017$603,000
-0.5%
135,503
+4.2%
0.01%0.0%
Q1 2017$606,000
-32.7%
130,098
-12.1%
0.01%
-40.0%
Q4 2016$901,000
+24.8%
148,026
+12.9%
0.01%0.0%
Q3 2016$722,000
+21.8%
131,110
-16.0%
0.01%
+25.0%
Q2 2016$593,000
+122.9%
156,013
+61.8%
0.01%
+100.0%
Q1 2016$266,000
-55.7%
96,402
-9.0%
0.00%
-42.9%
Q4 2015$601,000
+19.0%
105,978
+11.2%
0.01%0.0%
Q3 2015$505,000
-34.2%
95,323
+3.0%
0.01%
-36.4%
Q2 2015$768,000
+73.4%
92,564
-3.5%
0.01%
+120.0%
Q1 2015$443,000
+72.4%
95,937
+14.1%
0.01%
+66.7%
Q4 2014$257,000
+7.1%
84,103
-2.3%
0.00%0.0%
Q3 2014$240,000
-42.4%
86,061
-16.1%
0.00%
-40.0%
Q2 2014$417,000
-47.9%
102,548
-31.9%
0.01%
-50.0%
Q1 2014$800,000
+211.3%
150,610
+230.5%
0.01%
+150.0%
Q4 2013$257,000
-31.8%
45,573
-44.8%
0.00%
-55.6%
Q3 2013$377,000
+70.6%
82,561
+61.7%
0.01%
+125.0%
Q2 2013$221,00051,0430.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 7,590,000$28,842,0008.26%
Asymmetry Capital Management, L.P. 298,190$1,133,0002.08%
ARMISTICE CAPITAL, LLC 1,330,000$5,054,0001.92%
Belmont Global Advisors, Inc. 385,000$1,463,0001.40%
Paulson & Co. 27,756,668$105,475,0001.07%
Trellus Management Company, LLC 162,900$619,0001.01%
DAFNA Capital Management LLC 319,563$1,214,0000.96%
PURA VIDA INVESTMENTS, LLC 350,000$1,330,0000.56%
WALL STREET ASSOCIATES 269,300$1,023,0000.41%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,603,334$6,093,0000.34%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders